COLO B Coloplast A/S Class B

Coloplast A/S - Invitation to Coloplast's Capital Markets Day on 2 September 2025

Coloplast A/S - Invitation to Coloplast's Capital Markets Day on 2 September 2025

The event will take place on Tuesday, 2 September 2025 at Clarion Hotel (Copenhagen airport)

Ellehammersvej 20, 2770 Kastrup

from 10.30 - 17.00 CEST

(Central European Summer Time)

Coloplast invites institutional investors, equity analysts and media to attend our 2025 Capital Markets Day.

The event will be held in person at Clarion Hotel in Copenhagen, Denmark, with the option to join virtually for the plenary session.

The purpose of the event is to give institutional investors and financial analysts an introduction to the new 5-year strategy for the company, as well as to provide the opportunity to meet with the broader Management team.

The day will start with a plenary session, covering the introduction of the new Group strategy, a financial update, and the strategy for the Chronic Care businesses. In the afternoon, participants will be split into groups and rotate between four Q&A breakout sessions. Participation in the breakout sessions will be in-person only (with a replay of the presentations available after the event).

The formal program will end at 17.00, followed by an opportunity to meet the Coloplast management team in an informal setting.

Agenda in CEST

10.00 - 10.30  Registration

10.30 - 12.30  Plenary session: Group strategy and financials, strategy for Chronic Care and Voice and Respiratory Care

12.30 - 13.00  Lunch break

13.00 - 17.00  Q&A breakout sessions (incl. breaks)

17.00 - 18.30  Social activity (on premise)

Coloplast representatives

Plenary session:  

  Lars Rasmussen, Interim President and CEO

  Anders Lonning-Skovgaard, Executive Vice President, CFO

  Nicolai Buhl, Executive Vice President, Chronic Care

  Caroline Vagner Rosenstand, Executive Vice President, Voice & Respiratory Care

Breakout sessions:  

  Chronic Care deep dive:

  Mike DelVacchio, Senior Vice President, North America

  Thomas Bruhn, Senior Vice President, Emerging Markets

  Advanced Wound Care:

  Fertram Sigurjonsson, Founder and President, Kerecis

  Bernd Greiner, Senior Vice President, Adv. Wound Dressings

  Interventional Urology:

  Thomas NP Johns Jr, Executive Vice President, Interventional Urology

  Global Operations and People & Culture:

  Allan Rasmussen, Executive Vice President, Global Operations

  Dorthe Rønnau, Executive Vice President, People & Culture

In-person participation

If you wish to join us in-person and attend the plenary session and the Q&A breakout sessions, please register by sending an email to stating your full name, company, contact phone number and itinerary (if relevant).

Kindly register before Friday, 15 August 2025.

Virtual participation

Virtual participation will be possible for the plenary session.

A link for the webcast of the plenary sessions will be available on our website closer to the date.

For more information,

please contact:

Aleksandra Dimovska, Vice President

Direct tel.:

E-mail:  

Simone Dyrby Helvind, Sr. Manager  

Direct tel.:

E-mail:  

Julie Sommer Müggler, Coordinator   

Direct tel.:

Email:  

Attachment



EN
03/06/2025

Underlying

To request access to management, click here to engage with our
partner Phoenix-IR's CorporateAccessNetwork.com

Reports on Coloplast A/S Class B

ABGSC Healthcare Research ... (+2)
  • ABGSC Healthcare Research
  • Morten Larsen
ABGSC Healthcare Research ... (+2)
  • ABGSC Healthcare Research
  • Morten Larsen
 PRESS RELEASE

Coloplast A/S - Coloplast lancerer ny 5-årig strategi ’Impact4’

Coloplast A/S - Coloplast lancerer ny 5-årig strategi ’Impact4’ Den nye 5-årige strategi, Impact4, vil blive lanceret i dag på selskabets Capital Markets Day 2025. Strategien Impact4 sætter kunden i centrum og udstikker samtidig et ambitiøst mål for selskabet – at hjælpe 4 millioner mennesker på lang sigt. Med Impact4 fokuserer vi på fire strategiske prioriteter, der er afgørende for vores succes og værdiskabelse: ’Grow through innovative customer offerings’ ved at sætte standarden for sundhedspleje og ved at skabe et stærkt fokus på kunderne på tværs af alle vores forretningsområder.’Unl...

 PRESS RELEASE

Coloplast A/S - Coloplast presents new 5-year strategy, Impact4

Coloplast A/S - Coloplast presents new 5-year strategy, Impact4 The new 5-year strategy, Impact4, will be presented today at the company’s Capital Markets Day 2025 The Impact4 strategy puts customers at the centre of everything we do and sets an ambitious goal for the company – to help 4 million people in the long-term. With Impact4, we focus on four strategic priorities which are essential to our success and value creation: Grow through innovative customer offerings, by setting the standard of care and driving strong customer centricity across all our business areas.Unlock next level e...

 PRESS RELEASE

Coloplast A/S - Announcement no. 07/2025 - Coloplast fremlægger nye fi...

Coloplast A/S - Announcement no. 07/2025 - Coloplast fremlægger nye finansielle forventninger frem mod 2030 I forbindelse med lanceringen af Coloplasts nye 5-årige strategi, Impact4, offentliggør virksomheden en ny finansiel ambition med en organisk omsætningsvækst på 7-8 % (5-årige CAGR) frem til regnskabsåret 2029/30, en vækst i absolut EBIT* på niveau med eller over omsætningsvæksten i perioden og et afkast af investeret kapital (ROIC) på mere end 20 % i regnskabsåret 2029/30. På sin Capital Markets Day den 2. september 2025 vil Coloplast præsentere en ny 5-årig strategi, Impact4. I fo...

ResearchPool Subscriptions

Get the most out of your insights

Get in touch